相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
Jean-Damien Charrier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
Cynthia X. Ma et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo
Haijun Zhang et al.
CANCER RESEARCH (2010)
Targeted Radiosensitization of Cells Expressing Truncated DNA Polymerase β
Sari Neijenhuis et al.
CANCER RESEARCH (2010)
Radiosensitization of Epidermal Growth Factor Receptor/HER2-Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status
Randall J. Kimple et al.
CLINICAL CANCER RESEARCH (2010)
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Yun Dai et al.
CLINICAL CANCER RESEARCH (2010)
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
Asima Mukhopadhyay et al.
CLINICAL CANCER RESEARCH (2010)
Prospects for the Use of ATR Inhibitors to Treat Cancer
Jill M. Wagner et al.
PHARMACEUTICALS (2010)
The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2
Luke R. E. Harrison et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Exploiting synthetic lethal interactions for targeted cancer therapy
H. Christian Reinhardt et al.
CELL CYCLE (2009)
PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
Cathy Zhang et al.
CLINICAL CANCER RESEARCH (2009)
Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway
B. Cui et al.
MOLECULAR PHARMACOLOGY (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Keeping checkpoint kinases in line: new selective inhibitors in clinical trials
Susan Ashwell et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
Alessandra Blasina et al.
MOLECULAR CANCER THERAPEUTICS (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
Regulation of DNA double-strand break repair pathway choice
Meena Shrivastav et al.
CELL RESEARCH (2008)
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis
Chikako Kiyohara et al.
LUNG CANCER (2006)
Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase
Eva Petermann et al.
CELL CYCLE (2006)
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
Conrad C. Alano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
ER Plummer et al.
CLINICAL CANCER RESEARCH (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
CS Sorensen et al.
NATURE CELL BIOLOGY (2005)
G2 damage checkpoints: what is the turn-on?
MJ O'Connell et al.
JOURNAL OF CELL SCIENCE (2005)
UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress
IM Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining
HY Wang et al.
CANCER RESEARCH (2004)
Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway
K Yamane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation
Y Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer
MM Vilenchik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes
L Zou et al.
SCIENCE (2003)
Brca2 (XRCC11) deficiency results in enhanced mutagenesis
M Kraakman-van der Zwet et al.
MUTAGENESIS (2003)
S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function
WA Cliby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation
P Nghiem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles
CE Arris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
